English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Nov 6, 2024

California approves $10 billion climate bond for clean air and wildfire prevention
+ Pharmaceuticals
Patient Daily | Nov 6, 2024

Baylor researchers receive grants for innovative cell therapy projects
+ Pharmaceuticals
Patient Daily | Nov 6, 2024

Researchers receive grants for advancing cell therapy techniques
+ Pharmaceuticals
Patient Daily | Nov 6, 2024

Guidelines aim to ease insurer requirements for allergy treatment
+ Pharmaceuticals
Patient Daily | Nov 6, 2024

Baylor conducts study on CBT treatment for autistic children's anxiety
+ Pharmaceuticals
Patient Daily | Nov 5, 2024

American Lung Association appoints Vanessa M. Cohen to leadership board
+ Pharmaceuticals
Patient Daily | Nov 5, 2024

Veteran finds new purpose through art after wife's passing
+ Pharmaceuticals
Patient Daily | Nov 5, 2024

Voters support Washington's climate commitment by defeating Initiative 2117

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns